Cargando…
Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter]
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473843/ https://www.ncbi.nlm.nih.gov/pubmed/34588785 http://dx.doi.org/10.2147/IDR.S338460 |
| _version_ | 1784575084104515584 |
|---|---|
| author | Shuja, Syed Hasan Asad, Dayab Parekh, Abdul Samad |
| author_facet | Shuja, Syed Hasan Asad, Dayab Parekh, Abdul Samad |
| author_sort | Shuja, Syed Hasan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8473843 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84738432021-09-28 Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] Shuja, Syed Hasan Asad, Dayab Parekh, Abdul Samad Infect Drug Resist Letter Dove 2021-09-22 /pmc/articles/PMC8473843/ /pubmed/34588785 http://dx.doi.org/10.2147/IDR.S338460 Text en © 2021 Shuja et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Shuja, Syed Hasan Asad, Dayab Parekh, Abdul Samad Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] |
| title | Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] |
| title_full | Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] |
| title_fullStr | Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] |
| title_full_unstemmed | Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] |
| title_short | Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter] |
| title_sort | sinopharm! an unavoidable contender in the struggle against covid [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473843/ https://www.ncbi.nlm.nih.gov/pubmed/34588785 http://dx.doi.org/10.2147/IDR.S338460 |
| work_keys_str_mv | AT shujasyedhasan sinopharmanunavoidablecontenderinthestruggleagainstcovidletter AT asaddayab sinopharmanunavoidablecontenderinthestruggleagainstcovidletter AT parekhabdulsamad sinopharmanunavoidablecontenderinthestruggleagainstcovidletter |